Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells
- PMID: 1318976
- DOI: 10.1093/jnci/84.13.1017
Suppression of invasion by inducible expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in B16-F10 melanoma cells
Abstract
Background: We have previously shown that down-modulation (i.e., by antisense expression vector) of tissue inhibitor of metalloproteinase-1 (TIMP-1) in a noninvasive, nontumorigenic cell line led to an acquisition of an invasive, tumorigenic, and metastatic ability in these cells.
Purpose: Our purpose was to examine whether increased levels of murine TIMP-1 can directly suppress the invasive ability of malignant cells.
Methods: Murine B16-F10 melanoma cells were transfected with an expression vector to overproduce TIMP-1. Among these transfectants, we isolated five clonal cell lines (2-5, 2-8, 2-10, 6-5, and 6-9) that showed upregulation (i.e., overexpression) of TIMP-1.
Results: These cell lines had an increased basal level of TIMP-1 messenger RNA. TIMP-1 expression was under the control of the mouse metallothionein-I promoter, and four of these five clones (2-5, 2-8, 6-5, and 6-9) showed a threefold to 10-fold induction of TIMP-1 message when they were treated with 20 microM cadmium for 4 hours. An increase in TIMP-1 message led to an increase in TIMP-1 protein activity measured in the conditioned medium of clones 2-10 and 6-5. The invasive ability of the TIMP-1-upregulated cells was tested in a matrigel transwell invasion assay. All of the upregulated clones showed a significant reduction in their invasive ability, relative to the invasive ability of parental B16-F10 and the control 1-2 cell line; this reduction correlated with the level of TIMP-1 overexpression. Cadmium induction of TIMP-1 messenger RNA resulted in a further suppression of the invasive ability of the two inducible cell lines tested (i.e., 2-8 and 6-5).
Conclusions: Our data demonstrate that a specific upregulation of murine TIMP-1 expression in B16-F10 melanoma cells directly suppresses their invasive ability.
Similar articles
-
Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of the metalloproteinases-1.J Natl Cancer Inst. 1994 Feb 16;86(4):299-304. doi: 10.1093/jnci/86.4.299. J Natl Cancer Inst. 1994. PMID: 8158685
-
Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo.Clin Exp Metastasis. 1992 Nov;10(6):365-70. doi: 10.1007/BF00133464. Clin Exp Metastasis. 1992. PMID: 1451346
-
[4-acetamidophenyl retinoate (4-APR) inhibits reconstituted basement membrane invasion by tumor cells and its mechanism].Zhonghua Zhong Liu Za Zhi. 1997 May;19(3):196-9. Zhonghua Zhong Liu Za Zhi. 1997. PMID: 10920895 Chinese.
-
Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.Cancer Res. 1988 Oct 1;48(19):5539-45. Cancer Res. 1988. PMID: 3416307
-
Matrix metalloproteinases and tissue inhibitor of metalloproteinases: a review of their role in tumorigenesis and tissue invasion.Invasion Metastasis. 1989;9(6):391-405. Invasion Metastasis. 1989. PMID: 2689386 Review.
Cited by
-
The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.PLoS One. 2012;7(1):e30393. doi: 10.1371/journal.pone.0030393. Epub 2012 Jan 17. PLoS One. 2012. PMID: 22272343 Free PMC article.
-
Alpinia pricei Rhizome Extracts Induce Cell Cycle Arrest in Human Squamous Carcinoma KB Cells and Suppress Tumor Growth in Nude Mice.Evid Based Complement Alternat Med. 2011;2011:123815. doi: 10.1093/ecam/nep142. Epub 2011 Jun 18. Evid Based Complement Alternat Med. 2011. PMID: 19789215 Free PMC article.
-
Impaired microRNA processing causes corpus luteum insufficiency and infertility in mice.J Clin Invest. 2008 May;118(5):1944-54. doi: 10.1172/JCI33680. J Clin Invest. 2008. PMID: 18398510 Free PMC article.
-
Cisplatin and PI3kinase inhibition decrease invasion and migration of human ovarian carcinoma cells and regulate matrix-metalloproteinase expression.Cytoskeleton (Hoboken). 2010 Aug;67(8):535-44. doi: 10.1002/cm.20465. Cytoskeleton (Hoboken). 2010. PMID: 20607860 Free PMC article.
-
Matrix metalloproteinase inhibitors: applications in oncology.Invest New Drugs. 1999;17(4):387-99. doi: 10.1023/a:1006386406584. Invest New Drugs. 1999. PMID: 10759405 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous